MIR-CABG: A Randomized, Double-blind, Placebo-controlled, Single-Center Study to Evaluate the Impact of Mupirocin on Infection Rate Post Coronary Artery Bypass Grafting
Latest Information Update: 15 Oct 2013
At a glance
- Drugs Mupirocin (Primary)
- Indications Staphylococcal infections; Surgical wound infections
- Focus Therapeutic Use
- Acronyms MIR-CABG
- 15 Oct 2013 New trial record